June 11, 2025 8-Week Oral Therapy Approved for Acute HCV The FDA has approved Mavyret for the treatment of acute hepatitis C, offering physicians a pangenotypic, 8-week oral regimen for early intervention. Conexiant
June 16, 2025 Combination of Weight Gain, Age at Pregnancy Could Increase Breast Cancer Risk The ASCO Post
Trends in the Prevalence of Hepatitis C Infection During Pregnancy and Maternal-Infant Outcomes in the U.S., 1998 to 2018
June 16, 2025 Combination of Weight Gain, Age at Pregnancy Could Increase Breast Cancer Risk The ASCO Post
June 13, 2025 Menopause Medication May Help to Prevent Invasive Breast Cancer, Study Finds The ASCO Post
March 29, 2023 TTUHSC El Paso Hunt School of Dental Medicine Receives $10,000 Gift from Trellis Company Inside Dentistry